Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Preclinical study results support potential of NK1 antagonist in treating micturition disorders

Sep. 23, 1999

Ortho-McNeil designs new prostate-selective alpha1a-adrenoceptor antagonists

Sep. 15, 1999

Synaptic and Merck & Co. discontinue development of oral treatment for BPH

Sep. 13, 1999

Wider therapeutic index predicted for Ditropan XL compared to conventional Ditropan

Sep. 10, 1999

NexMed reports progress with topical treatments for sexual dysfunction

Sep. 9, 1999

FibroGen and Taisho to collaborate on kidney fibrosis research

Sep. 8, 1999

YM-31758: a potent and selective inhibitor of human prostatic 5alpha-reductase

Sep. 6, 1999

New treatment for urinary incontinence in the Recordati pipeline

Aug. 31, 1999

Long-term continuation rate good for Alza's overactive bladder therapy

Aug. 30, 1999

Long-term tolterodine reduces incontinence, is well tolerated

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...
Evaxion shares data from characterization of EVX-04
BioWorld Science
Evaxion A/S has developed EVX-04, an AI-designed DNA vaccine encoding 1β endogenous retroviruses (ERVs)-derived antigenic fragments to induce broad...